EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease

Takanobu Morishita iD, Paul J Martin, Yoshihiro Inamoto iD

Cells · 07.02.2025 · 14 (4) · 238

DOI: 10.3390/cells14040238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 07.02.2025. Verfasst von Takanobu Morishita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood and Marrow Transplantation & Cellular Therapy, Fujita Health University School of Medicine, Toyoake 470-1192, Japan. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic graft-versus-host disease (GVHD) occurs in 30–70% of patients after allogeneic hematopoietic cell transplantation (HCT) and increases the risks of morbidity and mortality. Systemic corticosteroids are the standard initial treatment, but one-third of patients require subsequent treatment with other systemic agents. Treatment decisions are often based on physicians’ experience. The expected treatment response rates in specific organs affected by chronic GVHD may inform such decisions. In this review, we identify 20 studies reporting treatment response rates in individual organs according to objective criteria, summarize the results, discuss the caveats in data interpretation, identify the unmet needs, and suggest future directions in the field. For cutaneous sclerosis, we observed large discrepancies in organ response rates according to the current NIH criteria and patient-reported improvement, highlighting the need for better measurement tools. High response rates for lung involvement with certain novel drugs deserve further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansChronic DiseaseTreatment Outcome

Stichwörter der Autor:innen

axatilimabbelumosudilchronic graft-versus-host diseaseextracorporeal photopheresisibrutinibkeyword allogeneic hematopoietic cell transplantationorgan responseruxolitinib

Autor:innen und Institutionen

  • Department of Blood and Marrow Transplantation & Cellular Therapy, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.
  • Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

ORCID-Profile: Takanobu Morishita, Yoshihiro Inamoto

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Morishita, T., Martin, P. J., & Inamoto, Y. (2025). Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease. Cells, 14(4), 238. https://doi.org/10.3390/cells14040238

Vancouver

Morishita T, Martin PJ, Inamoto Y. Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease. Cells. 2025;14(4):238. doi:10.3390/cells14040238

BibTeX
@article{Morishita2025,
  author = {Morishita, Takanobu and Martin, Paul J and Inamoto, Yoshihiro},
  title = {Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {238},
  doi = {10.3390/cells14040238}
}
Kostenlos starten →